当前位置:首页 - 行情中心 - 尚荣医疗(002551) - 财务分析 - 现金流量表

尚荣医疗

(002551)

  

流通市值:22.73亿  总市值:31.45亿
流通股本:6.11亿   总股本:8.45亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金450,935,122.491,297,944,556.7933,930,356.26554,433,695.98
收到的税费返还13,025,068.7845,082,219.8136,159,28623,135,796.12
收到其他与经营活动有关的现金6,663,740.2253,301,990.3120,971,410.0815,950,117.5
经营活动现金流入的平衡项目0000
经营活动现金流入小计470,623,931.491,396,328,766.82991,061,052.34593,519,609.6
购买商品、接受劳务支付的现金254,120,563.78867,342,947.97494,263,080.56311,531,273.8
支付给职工以及为职工支付的现金71,991,131.12276,504,078.7186,081,869.37123,330,987.42
支付的各项税费11,292,499.0538,080,46234,525,216.6419,091,752.29
支付其他与经营活动有关的现金35,508,030.5993,454,490.6880,070,877.6950,795,050.09
经营活动现金流出的平衡项目0000
经营活动现金流出小计372,912,224.541,275,381,979.35794,941,044.26504,749,063.6
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额97,711,706.95120,946,787.47196,120,008.0888,770,546
二、投资活动产生的现金流量:
收回投资收到的现金605,279,874.171,362,561,532.31936,922,880.81615,593,750
取得投资收益收到的现金2,968,563.543,736,544.14,566,061.622,660,571.14
处置固定资产、无形资产和其他长期资产收回的现金净额3,106.52,255,129.51118,331.11-
收到的其他与投资活动有关的现金-113,146.38--
投资活动现金流入的平衡项目0000
投资活动现金流入小计608,251,544.211,368,666,352.3941,607,273.54618,254,321.14
购建固定资产、无形资产和其他长期资产支付的现金9,990,070.8382,147,569.6526,036,165.5312,328,042.23
投资支付的现金517,000,0001,373,500,0001,093,167,764.87627,212,001.88
投资活动现金流出的平衡项目0000
投资活动现金流出小计526,990,070.831,455,647,569.651,119,203,930.4639,540,044.11
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额81,261,473.38-86,981,217.35-177,596,656.86-21,285,722.97
三、筹资活动产生的现金流量:
收到其他与筹资活动有关的现金1,650,00036,273,128.1337,038,959.2830,871,365.28
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,650,00036,273,128.1337,038,959.2830,871,365.28
偿还债务支付的现金206,465,880.0921,060,00080,720,00045,330,000
分配股利、利润或偿付利息支付的现金968,478.811,033,633.537,865,636.466,125,950.11
支付其他与筹资活动有关的现金60,250,0008,544,331.133,761,523.953,472,423.82
筹资活动现金流出平衡项目0000
筹资活动现金流出小计267,684,358.8940,637,964.6692,347,160.4154,928,373.93
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-266,034,358.89-4,364,836.53-55,308,201.13-24,057,008.65
四、汇率变动对现金及现金等价物的影响6,574,034.3917,140,717.372,612,218.391,561,677.04
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-80,487,144.1746,741,450.96-34,172,631.5244,989,491.42
加:期初现金及现金等价物余额453,987,150.22407,245,699.26407,245,699.26407,245,699.26
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额373,500,006.05453,987,150.22373,073,067.74452,235,190.68
补充资料:
净利润-25,912,519.2-18,672,975.69
资产减值准备-9,154,823.65--1,488,891.34
固定资产和投资性房地产折旧-87,871,937.63-43,264,645.49
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-87,871,937.63-43,264,645.49
无形资产摊销-14,519,146.79-69,106,009.18
长期待摊费用摊销-2,502,099.42-1,251,049.74
处置固定资产、无形资产和其他长期资产的损失--124,830.39-35,775.06
固定资产报废损失-1,607,173.67--
公允价值变动损失--1,322,766.63-51,081.77
财务费用--8,834,281.72--2,419,940.44
投资损失--2,701,178.47--4,075,054
递延所得税--1,562,490.84-933,937.4
其中:递延所得税资产减少--2,348,698.01-933,937.4
递延所得税负债增加-786,207.17--
存货的减少-105,767,900.84-21,394,683.99
经营性应收项目的减少--144,575,483.92--18,251,207.16
经营性应付项目的增加-2,896,228.26--39,228,135.6
现金的期末余额-453,987,150.22-452,235,190.68
减:现金的期初余额-407,245,699.26-407,245,699.26
公告日期2025-04-292025-04-292024-10-292024-08-27
审计意见(境内)标准无保留意见
TOP↑